Hearing a Heartbeat from Miles Away: Remote Detection of Undiagnosed AFPremiere Date: Friday, April 23, 2021
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Saturday, April 23, 2022
Note: Credit Is No Longer Available
|Mintu P. Turakhia, MD, MAS (Moderator)
Executive Director, Center for Digital Health
Stanford University School of Medicine
Director of Cardiac Electrophysiology
VA Palo Alto Health Care System
Palo Alto, CA
|Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL
Department of Family and Community Medicine
Lewis Katz School of Medicine at Temple University
|Khaldoun G. Tarakji, MD, MPH
Associate Section Head, Cardiac Electrophysiology
Heart, Vascular and Thoracic Institute
Director, HVTI Center for Digital Health and Telemedicine
Director, Center of International Medical Education, Education Institute
Atrial fibrillation (AF) is a common but often undiagnosed condition, with prevalence in the United States projected to increase from 5.2 million in 2010 to 12.1 million cases by 2030. AF may present with a wide range of symptoms or may be asymptomatic. Even when asymptomatic, AF increases the risk of stroke or systemic thromboembolism and all-cause mortality compared to no AF. Screening patients at-risk for AF can facilitate detection of AF and allow for initiation of potentially life-saving stroke preventive therapy. New technologies such as photoplethysmography via smartwatch, blood pressure monitors, handheld or smartphone-compatible ECG recorder, and patch ECG monitors offer many options to enable remote detection of undiagnosed AF.
The first episode of this CME Outfitters BriefCase series will focus on AF screening techniques and tools and how best to utilize them when providing care via telemedicine.
At the end of this CE activity, participants should be able to:
- Evaluate digital tools that aid in identifying undiagnosed NVAF when providing care via telemedicine.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Evaluate digital tools that aid in identifying undiagnosed NVAF for providing care via telemedicine.
Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance
Primary care physicians, cardiologists, PAs, nurse practitioners, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.75 contact hours (0.075 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
Note to PAs: PAs may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Turakhia reports that he receives grants from the American Heart Association; Apple Inc.; Bayer; Boehringer Ingelheim; Bristol Myers Squibb Company; Cardiva Medical, Inc.; Janssen Pharmaceuticals, Inc.; and SentreHEART, Inc. He is a consultant for Abbott; BIOTRONIK, Inc.; Cardiva Medical, Inc.; iRhythm Technologies, Inc.; Johnson & Johnson; Medtronic; Milestone Pharmaceuticals, Inc.; MyoKardia, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Sanofi. He receives other financial or material support as an editor for JAMA Cardiology.
Dr. Savoy has no disclosures to report.
Dr. Tarakji reports that he is a consultant for AliveCor, Inc.; Bristol Myers Squibb Company; Janssen Pharmaceuticals, Inc.; and Medtronic.
Jeffrey Helfand, DO (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).